APP Processing Assay Service
As a key target in neurobiological research, abnormal processing of amyloid precursor protein (APP) is closely related to the pathological progression of Alzheimer's disease (AD). Our in vitro APP processing assay service uses world-leading multidimensional analysis technology to provide accurate data support for drug development and mechanism research. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
APP is a type I transmembrane glycoprotein containing a large extracellular domain, a transmembrane region and a short intracellular tail. Its gene is located on human chromosome 21, and the subtype that is highly expressed in the central nervous system is APP695. Normal functions of APP include regulation of synaptic development, neural plasticity, cell signaling, and mineral transport. Its secretory fragments (such as sAPPα) have neuroprotective, neurotrophic and gene expression-promoting effects. APP processing is a complex enzymatic cleavage process involving two main competing pathways: the non-amyloidogenic pathway (dominated by α-secretase) and the amyloidogenic pathway (dominated by β/γ-secretase).
Available Assays at Creative Biolabs
- Dual Route Dynamic Monitoring
Simultaneous detection of the α-secretase non-amyloid pathway (generating neuroprotective sAPPα and p3 peptides) and the β-secretase amyloid pathway (generating pathogenic Aβ). It can identify key protease activities such as ADAM10, BACE1 and γ-secretase. Detection sensitivity reaches the pg level.
Fig.1 In iPSC-derived cortical neurons, secreted SAPP and Aβ were quantified by immunochemistry.2
- Multi-Dimensional Detection Platform
We offer a variety of detection methods, including but not limited to Chemiluminescent Immunoassay (CLIA): specificity > 90%, supports multiple sample types such as serum/plasma/cerebrospinal fluid. Enzyme-linked immunosorbent assay (ELISA) technology: can distinguish between full-length APP protein and its cleavage fragments (C83/C99). Mass spectrometry verification service: accurate identification of Aβ subtypes (such as Aβ40/Aβ42).
- Detailed Analysis of Pathological Mechanisms
Our scientists also provide analytical services, including but not limited to: detecting the effect of ubiquitination modification on APP metabolism (regulated by ligases such as VHL/HRD1), analyzing the damage of β/γ secretase co-localization on cell function, and evaluating the non-toxic cleavage of APP by metalloproteinases (such as Meprin β).
Featured Services
- We offer various subtypes of recombinant proteins such as APP770 and APP695 (purity > 95%).
- Support for antibody validation services: coverage of N-terminal/C-terminal epitopes, support for the entire process including WB/IF/IP.
- Personalized solution design: optimize detection conditions for different models such as neurons/cell lines/tumor cells.
Our company has 10 years of experience in neurobiological testing, and our service network covers more than 30 research institutions around the world. All experiments provide original data and bioinformatics analysis reports. Please contact us immediately to obtain customized testing solutions and technical white papers to help you break through the bottleneck of AD research!
References
- Zhang, Yun-wu, et al. "APP processing in Alzheimer's disease." Molecular brain 4 (2011): 1-13. Distributed under Open Access license CC BY 2.0, without modification.
- Bergström, Petra, et al. "Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation." Scientific reports 6.1 (2016): 29200. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)